Growth Metrics

Albemarle (ALB) Cash & Equivalents (2016 - 2025)

Albemarle (ALB) has disclosed Cash & Equivalents for 17 consecutive years, with $1.9 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 16.06% year-over-year to $1.9 billion, compared with a TTM value of $1.9 billion through Sep 2025, up 16.06%, and an annual FY2024 reading of $1.2 billion, up 33.97% over the prior year.
  • Cash & Equivalents was $1.9 billion for Q3 2025 at Albemarle, up from $1.8 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.1 billion in Q1 2024 and bottomed at $439.3 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $1.3 billion, with a median of $1.5 billion recorded in 2022.
  • The sharpest move saw Cash & Equivalents crashed 41.17% in 2021, then surged 242.47% in 2023.
  • Year by year, Cash & Equivalents stood at $439.3 million in 2021, then surged by 214.79% to $1.4 billion in 2022, then plummeted by 35.65% to $889.9 million in 2023, then surged by 33.97% to $1.2 billion in 2024, then soared by 62.03% to $1.9 billion in 2025.
  • Business Quant data shows Cash & Equivalents for ALB at $1.9 billion in Q3 2025, $1.8 billion in Q2 2025, and $1.5 billion in Q1 2025.